ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer
Low levels of high-density lipoprotein cholesterol (HDLc) have been associated with breast cancer risk, but several epidemiologic studies have reported contradictory results with regard to the relationship between apolipoprotein (apo) A-I and breast cancer. We aimed to determine the effects of human...
| Autores: | , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2016 |
| País: | España |
| Institución: | Universitat Autònoma de Barcelona |
| Repositorio: | Dipòsit Digital de Documents de la UAB |
| Idioma: | inglés |
| OAI Identifier: | oai:ddd.uab.cat:203755 |
| Acceso en línea: | https://ddd.uab.cat/record/203755 https://dx.doi.org/urn:doi:10.1038/srep36387 |
| Access Level: | acceso abierto |
| Palabra clave: | Animals Antineoplastic Agents Apolipoprotein A-I Breast Neoplasms Cell Proliferation Cell Survival Female Humans Lipoproteins, LDL MCF-7 Cells Mice Mice, Transgenic Molecular Mimicry Peptides Xenograft Model Antitumor Assays |
| id |
ES_6bf5a030d2616c7d6c323101f9497639 |
|---|---|
| oai_identifier_str |
oai:ddd.uab.cat:203755 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancerCedó, Lídia|||0000-0003-4354-3411Garcia León, Annabel|||0000-0003-3007-9306Baila-Rueda, LucíaSantos, David|||0000-0003-1157-4969Grijalva, VictorMartínez Cignoni, Melanie Raquel|||0000-0002-3469-7980Carbó, José María|||0000-0001-8301-5360Metso, JariLópez Vilaró, Laura|||0000-0002-5428-8017Zorzano Olarte, Antonio|||0000-0002-1638-0306Valledor, Annabel F.|||0000-0003-4232-2633Cenarro, AnaJauhiainen, Matti|||0000-0002-3836-3785Lerma Puertas, Enrique|||0000-0001-7908-2747Fogelman, Alan M.Reddy, Srinivasa T.Escolà-Gil, Joan Carles|||0000-0001-9021-2485Blanco Vaca, Francisco|||0000-0001-7380-5385AnimalsAntineoplastic AgentsApolipoprotein A-IBreast NeoplasmsCell ProliferationCell SurvivalFemaleHumansLipoproteins, LDLMCF-7 CellsMiceMice, TransgenicMolecular MimicryPeptidesXenograft Model Antitumor AssaysLow levels of high-density lipoprotein cholesterol (HDLc) have been associated with breast cancer risk, but several epidemiologic studies have reported contradictory results with regard to the relationship between apolipoprotein (apo) A-I and breast cancer. We aimed to determine the effects of human apoA-I overexpression and administration of specific apoA-I mimetic peptide (D-4F) on tumour progression by using mammary tumour virus-polyoma middle T-antigen transgenic (PyMT) mice as a model of inherited breast cancer. Expression of human apoA-I in the mice did not affect tumour onset and growth in PyMT transgenic mice, despite an increase in the HDLc level. In contrast, D-4F treatment significantly increased tumour latency and inhibited the development of tumours. The effects of D-4F on tumour development were independent of 27-hydroxycholesterol. However, D-4F treatment reduced the plasma oxidized low-density lipoprotein (oxLDL) levels in mice and prevented oxLDL-mediated proliferative response in human breast adenocarcinoma MCF-7 cells. In conclusion, our study shows that D-4F, but not apoA-I-containing HDL, hinders tumour growth in mice with inherited breast cancer in association with a higher protection against LDL oxidative modification.Universitat Autònoma de Barcelona 22016-01-0120162016-01-01Articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://ddd.uab.cat/record/203755https://dx.doi.org/urn:doi:10.1038/srep36387reponame:Dipòsit Digital de Documents de la UABinstname:Universitat Autònoma de BarcelonaInglésengMinisterio de Ciencia e Innovación https://doi.org/10.13039/501100004837 PI11/01076Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 PI12/00291Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 PI13/02507Instituto de Salud Carlos III https://doi.org/10.13039/501100004587 RD12-0042-0055Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 SAF2011-23402open accesshttp://purl.org/coar/access_right/c_abf2Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:ddd.uab.cat:2037552026-06-06T12:50:31Z |
| dc.title.none.fl_str_mv |
ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer |
| title |
ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer |
| spellingShingle |
ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer Cedó, Lídia|||0000-0003-4354-3411 Animals Antineoplastic Agents Apolipoprotein A-I Breast Neoplasms Cell Proliferation Cell Survival Female Humans Lipoproteins, LDL MCF-7 Cells Mice Mice, Transgenic Molecular Mimicry Peptides Xenograft Model Antitumor Assays |
| title_short |
ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer |
| title_full |
ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer |
| title_fullStr |
ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer |
| title_full_unstemmed |
ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer |
| title_sort |
ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer |
| dc.creator.none.fl_str_mv |
Cedó, Lídia|||0000-0003-4354-3411 Garcia León, Annabel|||0000-0003-3007-9306 Baila-Rueda, Lucía Santos, David|||0000-0003-1157-4969 Grijalva, Victor Martínez Cignoni, Melanie Raquel|||0000-0002-3469-7980 Carbó, José María|||0000-0001-8301-5360 Metso, Jari López Vilaró, Laura|||0000-0002-5428-8017 Zorzano Olarte, Antonio|||0000-0002-1638-0306 Valledor, Annabel F.|||0000-0003-4232-2633 Cenarro, Ana Jauhiainen, Matti|||0000-0002-3836-3785 Lerma Puertas, Enrique|||0000-0001-7908-2747 Fogelman, Alan M. Reddy, Srinivasa T. Escolà-Gil, Joan Carles|||0000-0001-9021-2485 Blanco Vaca, Francisco|||0000-0001-7380-5385 |
| author |
Cedó, Lídia|||0000-0003-4354-3411 |
| author_facet |
Cedó, Lídia|||0000-0003-4354-3411 Garcia León, Annabel|||0000-0003-3007-9306 Baila-Rueda, Lucía Santos, David|||0000-0003-1157-4969 Grijalva, Victor Martínez Cignoni, Melanie Raquel|||0000-0002-3469-7980 Carbó, José María|||0000-0001-8301-5360 Metso, Jari López Vilaró, Laura|||0000-0002-5428-8017 Zorzano Olarte, Antonio|||0000-0002-1638-0306 Valledor, Annabel F.|||0000-0003-4232-2633 Cenarro, Ana Jauhiainen, Matti|||0000-0002-3836-3785 Lerma Puertas, Enrique|||0000-0001-7908-2747 Fogelman, Alan M. Reddy, Srinivasa T. Escolà-Gil, Joan Carles|||0000-0001-9021-2485 Blanco Vaca, Francisco|||0000-0001-7380-5385 |
| author_role |
author |
| author2 |
Garcia León, Annabel|||0000-0003-3007-9306 Baila-Rueda, Lucía Santos, David|||0000-0003-1157-4969 Grijalva, Victor Martínez Cignoni, Melanie Raquel|||0000-0002-3469-7980 Carbó, José María|||0000-0001-8301-5360 Metso, Jari López Vilaró, Laura|||0000-0002-5428-8017 Zorzano Olarte, Antonio|||0000-0002-1638-0306 Valledor, Annabel F.|||0000-0003-4232-2633 Cenarro, Ana Jauhiainen, Matti|||0000-0002-3836-3785 Lerma Puertas, Enrique|||0000-0001-7908-2747 Fogelman, Alan M. Reddy, Srinivasa T. Escolà-Gil, Joan Carles|||0000-0001-9021-2485 Blanco Vaca, Francisco|||0000-0001-7380-5385 |
| author2_role |
author author author author author author author author author author author author author author author author author |
| dc.contributor.none.fl_str_mv |
Universitat Autònoma de Barcelona |
| dc.subject.none.fl_str_mv |
Animals Antineoplastic Agents Apolipoprotein A-I Breast Neoplasms Cell Proliferation Cell Survival Female Humans Lipoproteins, LDL MCF-7 Cells Mice Mice, Transgenic Molecular Mimicry Peptides Xenograft Model Antitumor Assays |
| topic |
Animals Antineoplastic Agents Apolipoprotein A-I Breast Neoplasms Cell Proliferation Cell Survival Female Humans Lipoproteins, LDL MCF-7 Cells Mice Mice, Transgenic Molecular Mimicry Peptides Xenograft Model Antitumor Assays |
| description |
Low levels of high-density lipoprotein cholesterol (HDLc) have been associated with breast cancer risk, but several epidemiologic studies have reported contradictory results with regard to the relationship between apolipoprotein (apo) A-I and breast cancer. We aimed to determine the effects of human apoA-I overexpression and administration of specific apoA-I mimetic peptide (D-4F) on tumour progression by using mammary tumour virus-polyoma middle T-antigen transgenic (PyMT) mice as a model of inherited breast cancer. Expression of human apoA-I in the mice did not affect tumour onset and growth in PyMT transgenic mice, despite an increase in the HDLc level. In contrast, D-4F treatment significantly increased tumour latency and inhibited the development of tumours. The effects of D-4F on tumour development were independent of 27-hydroxycholesterol. However, D-4F treatment reduced the plasma oxidized low-density lipoprotein (oxLDL) levels in mice and prevented oxLDL-mediated proliferative response in human breast adenocarcinoma MCF-7 cells. In conclusion, our study shows that D-4F, but not apoA-I-containing HDL, hinders tumour growth in mice with inherited breast cancer in association with a higher protection against LDL oxidative modification. |
| publishDate |
2016 |
| dc.date.none.fl_str_mv |
2 2016-01-01 2016 2016-01-01 |
| dc.type.none.fl_str_mv |
Article http://purl.org/coar/resource_type/c_6501 VoR http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
https://ddd.uab.cat/record/203755 https://dx.doi.org/urn:doi:10.1038/srep36387 |
| url |
https://ddd.uab.cat/record/203755 https://dx.doi.org/urn:doi:10.1038/srep36387 |
| dc.language.none.fl_str_mv |
Inglés eng |
| language_invalid_str_mv |
Inglés |
| language |
eng |
| dc.relation.none.fl_str_mv |
Ministerio de Ciencia e Innovación https://doi.org/10.13039/501100004837 PI11/01076 Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 PI12/00291 Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 PI13/02507 Instituto de Salud Carlos III https://doi.org/10.13039/501100004587 RD12-0042-0055 Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 SAF2011-23402 |
| dc.rights.none.fl_str_mv |
open access http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by/4.0/ |
| dc.rights.openaire.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
open access http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.source.none.fl_str_mv |
reponame:Dipòsit Digital de Documents de la UAB instname:Universitat Autònoma de Barcelona |
| instname_str |
Universitat Autònoma de Barcelona |
| reponame_str |
Dipòsit Digital de Documents de la UAB |
| collection |
Dipòsit Digital de Documents de la UAB |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869410234175324160 |
| score |
15,300719 |